Skip to main content
OpenTrials

Clinical trial condition

Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast Cancer

Explore clinical trials studying Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast Cancer trial results

Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT06805812

Conditions
Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more
Locations
  • Centro di Riferimento Oncologico IRCCS Aviano, Italy
  • Azienda Socio Sanitaria Territoriale degli Spedali Civili Brescia, Italy
  • Humanitas Istituto Clinico Catanese Catania, Italy
  • ASST Lariana - Ospedale Sant'Anna Como, Italy
View all 24 locations
View Trial Details
Completed

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

NCT01576666

Conditions
Advanced Pancreatic Adenocarcinoma, Advanced Solid Tumors, Astrocytoma, +35 more
Locations
  • Cedars Sinai Medical Center SC Los Angeles, California, United States
  • University of California San Francisco UCSF (SC) San Francisco, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 Tampa, Florida, United States
  • Dana Farber Cancer Institute Dana SC Boston, Massachusetts, United States
View all 23 locations
View Trial Details

Related conditions